Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
The decision to come work here earlier this year has been a very positive one
Was gefällt dir am besten am Führungsteam?
Too new an emplpyee to comment
Was ist das Beste an Ihrem Vergütungspaket?
Strong Medical coverage, vacation policy, company 401k match
Was macht Sie bei der Arbeit am glücklichsten?
Engaging colleagues, to meet their needs
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
The company's commitment to patients
Other Employee Reviews for Karyopharm Therapeutics
×